Literature DB >> 10998127

Adenoviral gene transfer to the injured spinal cord of the adult rat.

A B Huber1, M U Ehrengruber, M E Schwab, C Brösamle.   

Abstract

We have investigated gene transfer to the injured adult rat spinal cord by the use of a recombinant adenovirus. 105 or 5 x 106 plaque-forming units (pfu) of a replication-defective adenoviral vector carrying the green fluorescent protein (GFP) reporter gene were injected into a dorsal hemisection lesion at spinal level T8. Gene expression and inflammatory responses were studied 4, 8 and 21 days after surgery. Numerous cells within 3 mm on each side of the lesion were found to express high levels of GFP at 4 days after infection as shown by GFP fluorescence and immunohistochemistry. At 8 days, expression was still strong although weaker than at 4 days. After 21 days, transgene expression had almost ceased. Expression was neither higher nor more prolonged in animals that had received the higher vector dose. Delayed injection 1 week after spinal injury also did not increase transgene expression. Infected cell types were identified immunohistochemically. The most prominent transduced cells were spinal motoneurons. Additionally, we could identify other neurons, astrocytes, oligodendrocytes and peripheral cells infiltrating the lesion site. The glial and inflammatory reaction at and around the lesion was studied by cresyl violet histology, alpha-GFAP, OX42 and alpha-CD-8 immunohistochemistry. No significant differences from controls were found in the low virus group; in the high virus group a strong invasion of CD-8-positive lymphocytes was found. Open-field locomotion analysis showed virus-infected animals performing as well as control animals. Adenoviral gene transfer may be an efficient way to introduce factors to the injured spinal cord in paradigms of research or therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998127     DOI: 10.1046/j.1460-9568.2000.00255.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  5 in total

1.  Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems.

Authors:  Ahmed A Abdellatif; Jennifer L Pelt; Richard L Benton; Russell M Howard; Pantelis Tsoulfas; Peipei Ping; Xiao-Ming Xu; Scott R Whittemore
Journal:  J Neurosci Res       Date:  2006-08-15       Impact factor: 4.164

2.  Survival and regeneration of rubrospinal neurons 1 year after spinal cord injury.

Authors:  Brian K Kwon; Jie Liu; Corrie Messerer; Nao R Kobayashi; John McGraw; Loren Oschipok; Wolfram Tetzlaff
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

3.  Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury.

Authors:  Laura De Laporte; Anna Lei Yan; Lonnie D Shea
Journal:  Biomaterials       Date:  2009-01-13       Impact factor: 12.479

Review 4.  Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury.

Authors:  Anastasiia O Sosnovtseva; Olga V Stepanova; Aleksei A Stepanenko; Anastasia D Voronova; Andrey V Chadin; Marat P Valikhov; Vladimir P Chekhonin
Journal:  Front Pharmacol       Date:  2022-01-10       Impact factor: 5.810

5.  Targeting Motor End Plates for Delivery of Adenoviruses: An Approach to Maximize Uptake and Transduction of Spinal Cord Motor Neurons.

Authors:  Andrew Paul Tosolini; Renée Morris
Journal:  Sci Rep       Date:  2016-09-13       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.